measuregroup/AID153526

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID174515646_AID153526_PMID3397991_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103579573_AID153526_PMID3397991_VALUE1 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID174505714_AID153526_PMID3397991_VALUE2 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID174515646_AID153526_PMID3397991_VALUE4
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/cell/CELLID73096
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title	Antitumor activity against P388/ADR, in ip implanted CDF1 mice, treated ip, qd 1-9 measured as optimal dose
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID174515646 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID174505714 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103579573
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID153526

Total number of triples: 12.